Markets

Smith & Nephew (SNN) Crumbles: Stock Falls by 5.7% - Tale of the Tape

Smith & Nephew plc ( SNN ) saw a big move last session, as the company's shares fell nearly 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for SNN as the stock is now up more than 18.0% in the past one-month time frame.

This slump shouldn't be too much of a surprise to investors, as the company has seen 2 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

SNN currently has a Zacks Rank #3 (Hold) while its Earnings ESP is zero.

Some better-ranked stocks in the health care sector include Cardica Inc. ( CRDC ), ICU Medical, Inc. ( ICUI ) and Venaxis, Inc. ( APPY ). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SMITH & NEPHEW (SNN): Free Stock Analysis Report

CARDICA INC (CRDC): Free Stock Analysis Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

VENAXIS INC (APPY): Get Free Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ICUI SNN

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More